Lonza Group AG (LZAGY)
Lonza Group AG is a Swiss life sciences company whose depositary receipt is listed on OTC Markets under the symbol LZAG.Y. The underlying issuer operates as a contract development and manufacturing organization serving pharma and biotech customers across Europe, the Americas, and the Asia-Pacific region. Its activities are organized into three segments: Integrated Biologics, which covers biologics development and manufacturing services; Advanced Synthesis, which focuses on antibody-drug conjugates, other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and Specialized Modalities, which includes technologies for cell and gene, microbial, bioscience, and mRNA applications. Incorporated in 1897 and based in Basel, Switzerland, Lonza Group AG has a long operating history in the healthcare and life sciences tools and services space.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-LZAG.Y
|
$69.87
|
0.7% Upside
|
Fair
|
$80.46
|
15.9% Upside
|
Fair
|
Good
|
—
|
—
|
0.4
|
0.6%
|
July 22, 2026
|
43.5x
|
5.0x
|
6.1x
|
48.713 B
|
54.951 B
|
10.6%
|
100.0%
|
7.9
|
-101.8%
|
-18.2%
|
